Coupled Plasma Filtration Adsorption (CPFA) Plus Continuous Veno-Venous Haemofiltration (CVVH) Versus CVVH Alone As an Adjunctive Therapy in the Treatment of Sepsis

Overview

Journal EXCLI J

Specialty Biology

Date 2015 Nov 25

PMID 26600735

Citations 9

Authors

Juita Hassan

Rizna Abdul Cader

Norella Ct Kong

Marlyn Mohd

Abdul Raha Rahman

Rozita Hod

Affiliations

Soon will be listed here.

Abstract

Purpose: To compare the efficacy of Coupled Plasma Filtration and Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunct treatment of sepsis in terms of haemodynamic stability, inotropic requirement and inflammatory mediators.

Design And Methods: Prospective randomized controlled trial involving septic patients with/without acute kidney injury (AKI) whom were randomized to receive CPFA + CVVH or CVVH alone. Haemodynamic parameters including inotropic requirements and inflammatory mediators [procalcitonin (PCT) and C reactive protein (CRP)] were measured.

Results: Twenty-three patients [CPFA + CVVH (n = 11), CVVH (n = 12)] were enrolled. Haemodynamic stability occurred earlier and sustained in the CPFA + CVVH group with an increase in diastolic blood pressure (p = 0.001 vs. p = 0.226) and mean arterial pressure (p = 0.001 vs. p = 0.575) at the end of treatment with no increment in inotropic requirement. Both groups had a reduction in PCT and CRP (CPFA + CVVH: p = 0.003, p = 0.026 and CVVH: p = 0.008, p = 0.071 respectively). The length of intensive care unit stay, hospital stay and 30 day outcomes were similar between the groups. There was an inverse association between serum albumin and CRP (p = 0.018). Serum albumin positively correlated with systolic blood pressure (p = 0.012) and diastolic blood pressure (p = 0.009). We found a trend between CRP and length of hospital stay (p = 0.056). Patients with a lower PCT at 24 h had a better outcome (survival) than those with a higher PCT (p = 0.045).

Conclusion: CPFA is a feasible, albeit expensive adjunctive extracorporeal treatment that may be superior to CVVH alone in the treatment of severe sepsis.

Citing Articles

Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements.

Mehta Y, Paul R, Ansari A, Banerjee T, Gunaydin S, Nassiri A World J Crit Care Med. 2023; 12(2):71-88.

PMID: 37034019 PMC: 10075046. DOI: 10.5492/wjccm.v12.i2.71.

Relationship between red blood cell distribution width-to-albumin ratio and outcome of septic patients with atrial fibrillation: a retrospective cohort study.

Gu Y, Yang D, Huang Z, Chen Y, Dai Z BMC Cardiovasc Disord. 2022; 22(1):538.

PMID: 36494633 PMC: 9733276. DOI: 10.1186/s12872-022-02975-1.

Coupled plasma filtration adsorption for the treatment of sepsis or septic shock: a systematic review and meta-analysis.

Li Y, Li H, Guo J, Wang Y, Zhang D BMC Infect Dis. 2022; 22(1):714.

PMID: 36038815 PMC: 9422100. DOI: 10.1186/s12879-022-07689-5.

Blood purification for sepsis: an overview.

Zhang L, Feng Y, Fu P Precis Clin Med. 2022; 4(1):45-55.

PMID: 35693122 PMC: 8982546. DOI: 10.1093/pcmedi/pbab005.

High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.

Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P Intensive Care Med. 2021; 47(11):1303-1311.

PMID: 34601619 DOI: 10.1007/s00134-021-06501-3.

References

Bagshaw S, George C, Bellomo R . Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008; 12(2):R47. PMC: 2447598. DOI: 10.1186/cc6863. View

Bossink A, Groeneveld A, Koffeman G, Becker A . Prediction of shock in febrile medical patients with a clinical infection. Crit Care Med. 2001; 29(1):25-31. DOI: 10.1097/00003246-200101000-00006. View

Meisner , Tschaikowsky , Palmaers , Schmidt . Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 2000; 3(1):45-50. PMC: 29013. DOI: 10.1186/cc306. View

Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A . A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002; 30(6):1250-5. DOI: 10.1097/00003246-200206000-00015. View

Dellinger R, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J . Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30(4):536-55. DOI: 10.1007/s00134-004-2210-z. View

Hoste E, Lameire N, Vanholder R, Benoit D, Decruyenaere J, Colardyn F . Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol. 2003; 14(4):1022-30. DOI: 10.1097/01.asn.0000059863.48590.e9. View

Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M . Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med. 2003; 29(5):703-8. DOI: 10.1007/s00134-003-1724-0. View

Castelli G, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R . Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol. 2006; 72(1-2):69-80. View

Hennessy D, Juzwishin K, Yergens D, Noseworthy T, Doig C . Outcomes of elderly survivors of intensive care: a review of the literature. Chest. 2005; 127(5):1764-74. DOI: 10.1378/chest.127.5.1764. View

10.

Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K . MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999; 189(11):1777-82. PMC: 2193086. DOI: 10.1084/jem.189.11.1777. View

11.

Boussekey N, Leroy O, Georges H, Devos P, Descrivan T, Guery B . Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection. 2005; 33(4):257-63. PMC: 7102380. DOI: 10.1007/s15010-005-4096-2. View

12.

Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau G . Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164(3):396-402. DOI: 10.1164/ajrccm.164.3.2009052. View

13.

Tetta C, Cavaillon J, Schulze M, Ronco C, Ghezzi P, Camussi G . Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant. 1998; 13(6):1458-64. DOI: 10.1093/ndt/13.6.1458. View

14.

Cesano G, Livigni S, Vallero A, Olivieri C, Borca M, Quarello F . [Treatment of septic shock with the use of CPFA (associated plasma filtration and adsorption): impact on hemodynamics monitored with PiCCO ]. G Ital Nefrol. 2003; 20(3):258-63. View

15.

Meynaar I, Droog W, Batstra M, Vreede R, Herbrink P . In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011; 2011:594645. PMC: 3113363. DOI: 10.1155/2011/594645. View

16.

Formica M, Inguaggiato P, Bainotti S, Wratten M . Coupled plasma filtration adsorption. Contrib Nephrol. 2007; 156:405-10. DOI: 10.1159/000102131. View

17.

Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud J . Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol. 2002; 15(2):150-7. View

18.

Nishikura T . The clearance of procalcitonin (PCT) during continuous veno-venous hemodiafiltration (CVVHD). Intensive Care Med. 1999; 25(10):1198-9. DOI: 10.1007/s001340051041. View

19.

Antonio Lopes J, Fernandes P, Jorge S, Resina C, Santos C, Pereira A . Long-term risk of mortality after acute kidney injury in patients with sepsis: a contemporary analysis. BMC Nephrol. 2010; 11:9. PMC: 2891734. DOI: 10.1186/1471-2369-11-9. View

20.

Annane D, Bellissant E, Cavaillon J . Septic shock. Lancet. 2005; 365(9453):63-78. DOI: 10.1016/S0140-6736(04)17667-8. View